Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: ajtj99 who wrote (57788)	4/26/2022 11:12:00 PM
From: h_	Read Replies (1) \| Respond to of 97963

Sorry, I'm a day behind but I'm wondering where you got this from: The mRNA therapies were designed to mitigate serious disease, not stop it completely. The endpoint of the Pfizer study was mild to moderate symptom reduction which is arguably opposite to this. I don't believe I've ever come across what they were supposedly designed for, but I would expect that the study presented to the FDA for approval would be set up to show they do what they were designed for. OCICBW, thanks.